Early life stress, HPA axis, and depression by Tofoli, Sandra Marcia de Carvalho et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.3922/j.psns.2011.2.008
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Tofoli, S. M. D. C., Baes, C. V. W., Martins, C. M. S., & Juruena, M. (2011). Early life stress, HPA axis, and
depression. Psychology and Neuroscience, 4(2), 229-234. 10.3922/j.psns.2011.2.008
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 01. May. 2017
Psychology & Neuroscience, 2011, 4, 2,  229 - 234
DOI: 10.3922/j.psns.2011.2.008
PSYCHOLOGY 
NEUROSCIENCE
Early life stress, HPA axis, and depression
Sandra Marcia de Carvalho Tofoli, Cristiane Von Werne Baes, Camila Maria Severi Martins and 
Mario Juruena
Universidade de São Paulo, Ribeirão Preto, SP, Brazil
Abstract
Considerable evidence from various studies suggests a preeminent role for early adverse experiences in the development of 
psychopathology, especially depression. The most recent studies reviewed herein suggest that early life stressors are associated 
with an increased risk for mood disorders in adulthood. This review examines the emerging literature on the relationship between 
stress, hypothalamic-pituitary-adrenal (HPA) axis function, and depression and the role of early life stress as an important risk 
factor for HPA axis dysregulation. The most consistent findings in the literature show increased activity of the HPA axis in 
depression associated with hypercortisolemia and reduced inhibitory feedback. Moreover, HPA axis changes appear to be state-
dependent, tending to improve upon resolution of the depressive syndrome. Interestingly, persistent HPA hyperactivity has been 
associated with higher rates of relapse. These studies suggest that an evaluation of the HPA axis during antidepressant treatment 
may help identify patients who are at a higher risk for relapse. These findings suggest that this dysregulation of the HPA axis 
is partially attributable to an imbalance between glucocorticoid and mineralocorticoid receptors. Evidence has consistently 
demonstrated that glucocorticoid receptor function is impaired in major depression, but few studies have assessed the activity 
of mineralocorticoid receptors in depression. Thus, more studies are needed to elucidate this issue. Keywords: early life stress, 
childhood trauma, depression, treatment-resistant depression, hypothalamic-pituitary-adrenal axis.
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Introduction
Psychological stress may change the internal 
homeostatic state of an individual. During acute 
stress, adaptive physiological responses occur, 
including increased adrenocortical hormone secretion, 
primarily cortisol. Whenever an acute interruption of 
this balance occurs, illness may result. Particularly 
interesting are psychological stress (i.e., stress in 
the mind) and the interactions with the nervous, 
endocrine, and immune systems.
A key problem in diagnosis is the fact that elaborate 
classification systems that exist today are solely 
based on subjective descriptions of symptoms. Such 
detailed phenomenology includes the description of 
multiple clinical subtypes, but no biological feature can 
distinguish one subtype from another. This approach 
states that the causes, development, and outcomes 
of disorders are determined by the relationships 
between psychological, social, and cultural factors 
and biochemistry and physiology. Biochemistry and 
physiology are not disconnected or different from 
the rest of our experiences and life events (Juruena, 
Marques, Mello, & Mello, 2007).
Early life stress
The concept of early life stress is quite broad and 
includes the different traumatic experiences that occur 
during childhood and adolescence, which may have 
repercussions in adulthood. Among these are parental loss, 
separation from parents, childhood illness, family violence, 
and deprivation of food, clothing, shelter, and love.
In agreement with Bernstein et al. (1994), 
childhood maltreatment may be subdivided into the 
following domains:
1. Physical abuse: physical aggression by someone 
older, with the risk of or result of injury.
2. Emotional abuse: verbal aggression that affects 
the welfare or morale of the child or any conduct that 
humiliates, embarrasses, or threatens the child.
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3. Sexual abuse: any type of sexual contact or conduct 
between a child and someone older.
4. Emotional neglect: failure of caretakers to provide for 
basic emotional and psychological needs such as love, 
motivation, and support.
5. Physical neglect: failure of caretakers to provide for 
basic physical needs such as feeding, a home, security, 
supervision, and health (Bernstein et al., 1994, 2003).
Childhood maltreatment is a major social problem. 
It is a complex global phenomenon that does not respect 
boundaries of class, race, religion, age, or educational 
level and can occur both publicly and privately, resulting 
in serious physical injury or even death. Moreover, its 
psychological consequences can acutely affect a child’s 
mental health well into adulthood (Friedrich, 1998; 
Cruz, Silva, & Alves, 2007). 
Early life stress is associated with a diverse 
range of psychiatric consequences. In children 
and adolescents, it increases the risk of behavioral 
problems, including internalizing and externalizing 
behavior. Internalizing refers to behavioral 
symptoms reflected by anxiety, depression, 
somatic complaints, and inhibition. Externalizing 
refers to behavioral symptoms reflected by 
aggression, delinquency, and increased activity 
level. Sexual behavior problems most likely fall into 
this domain (Friedrich, 1998).
Considerable evidence from various studies 
suggests a preeminent role for early adverse experiences 
in the development of mood and anxiety disorders. 
Child abuse and neglect can be perceived as agents 
for neurodevelopmental disruption and, depending on 
when it occurs, can cause serious neurological “scars” 
in some structures, which could make some individuals 
vulnerable to certain types of psychopathology, 
especially depression, posttraumatic stress disorder 
(PTSD), and substance abuse (Cohen, Brown, & Smaile, 
2001; Heim et al., 2000; Juruena, 2007).
Psychoneuroendocrinology
The maintenance of the internal homeostatic state 
of an individual is proposed to be based on the ability of 
circulating glucocorticoids to exert negative feedback on 
the secretion of hypothalamic-pituitary-adrenal (HPA) 
hormones through binding to mineralocorticoid receptors 
(MRs) and glucocorticoid receptors (GRs), limiting the 
vulnerability to diseases related to psychological stress 
in genetically predisposed individuals.
The HPA axis response to stress can be thought 
of as a mirror of the organism’s response to stress: 
acute responses are generally adaptive, but excessive 
or prolonged responses can lead to deleterious effects. 
These deleterious effects, which may not be clinically 
apparent, have the potential to serve as endophenotypic 
markers of disease susceptibility (Juruena, Cleare, 
Bauer, & Pariante, 2003; Mello et al., 2007). Because 
the HPA axis is activated in response to stressors, 
stressful events in early life may also have an 
etiologically significant role in the HPA abnormalities 
found in psychiatric disorders including Depression, 
Bipolar disorder, Anxiety disorders, Eating disorders, 
Schizophrenia, Substance abuse, Dissociative disorder, 
and PTSD, among other medical illnesses (Juruena, 
Cleare, & Pariante, 2004; Mello et al., 2007).
According to Favarelli et al. (2010), the 
effect of childhood trauma on the development 
of psychopathology in adulthood is attributable 
to the HPA axis, which when activated during the 
developmental process would be permanently 
unstable, hyperstimulated, vulnerable, or dysfunctional 
(Favarelli et al., 2010). Similar findings were found in 
a recent study by Heim, Mletzko, Purselle, Musselman, 
and Nemeroff (2008) that assessed HPA axis function 
in men with and without major depression and 
childhood abuse. Abused men exhibited an increased 
cortisol response compared with non-abused men, 
regardless of the presence of major depression. 
Increased responses were associated with exposure to 
both sexual and physical abuse and were correlated 
with abuse severity. Their results suggested that 
childhood maltreatment is associated with impaired 
glucocorticoid-mediated feedback control of the HPA 
axis under stimulated conditions (Heim et al., 2008).
Depression
Approximately eight out of 10 people who 
experience a major depressive episode will have one 
or more further episodes during their lifetime (i.e., a 
recurrent major depressive disorder); therefore, early 
diagnosis and effective treatment are vital for reducing 
the effect of depression on the life of the individual, 
family, and community (Fava, Park, & Sonino, 2006; 
Juruena et al., 2003). Studies estimate that the currently 
Figure 1. Model of vulnerability and stress. Adapted from 
Juruena, 2007. 
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available antidepressant treatments are ineffective in 30-
50% of treatment-resistant depression (TRD), i.e., are 
considered resistant those patients who do not respond 
to antidepressant treatment performed with a sufficient 
of time at an adequate dose.
Approximately 60% of cases of depressive episodes are 
preceded by exposure to stressors, especially psychosocial 
stressors (Joca, Padovan, & Guimarães, 2003). Among 
the factors associated with depression in adulthood are 
exposure to childhood stressors such as the death of a parent 
or substitute, maternal deprivation, paternal abandonment, 
parental separation, and divorce (Zavaschi et al., 2002).
Maltreated children have a moderately increased 
risk of depression in adolescence and adulthood, 
which will partially mirror the family context in which 
the maltreatment occurred. Depression is common. 
Approximately one-quarter to one-third of maltreated 
children will meet the criteria for major depression by 
their late 20s, thus representing a substantial public 
health burden. For many of the affected individuals, the 
onset of depression begins in childhood, underscoring 
the importance of focusing on early intervention before 
the symptoms of depression appear in the abused and 
neglected children (Mello et al., 2009).
Hormones play a critical role in the development 
and expression of a wide range of behaviors. One 
aspect of the influence of hormones on behavior is 
their potential contribution to the pathophysiology of 
psychiatric disorders and the mechanism of action of 
psychotropic drugs, particularly in depression. Of the 
endocrine axes, the HPA axis has been the most widely 
studied. It plays a fundamental role in the response to 
external and internal stimuli, including psychological 
stressors. Abnormalities in the function of the HPA 
axis have been described in people who experience 
psychiatric disorders (Nemeroff, 1996).
Studies conducted in both animals and humans 
suggest that stress experienced during the early phases 
of development can induce persistent changes in the 
ability of the HPA axis to respond to stress in adulthood, 
increasing the susceptibility to depression (Glover & 
O’Connor, 2002). Evidence suggests that neurochemical 
and molecular changes induced by stressful situations 
and depression trigger changes in the HPA axis. Findings 
derived from multiple lines of research have provided 
evidence that during depression, dysfunction of limbic 
structures, including the hypothalamus and hippocampus, 
results in hypersecretion of corticotropin-releasing 
factor (CRF), dehydroepiandrosterone, and vasopressin, 
which in turn determines HPA activation. A flaw in this 
system caused by factors such as excessive stress, high 
glucocorticoid levels, social isolation, and depressive 
symptoms results in difficulty adapting to stress and can 
predispose the individual to depression by impairing 
hippocampal serotonergic neurotransmission (Holsboer, 
2000; Joca et al., 2003; Juruena et al., 2004; Figure 2).
Hyperactivity of the HPA axis in major depression 
is one of the most consistent findings in psychiatry. A 
significant percentage of patients with major depression 
have been shown to exhibit increased concentrations 
of cortisol (i.e., the endogenous glucocorticoid in 
humans) in plasma, urine, and cerebrospinal fluid, an 
exaggerated cortisol response to adrenocorticotropic 
hormone, and an enlargement of both the pituitary and 
adrenal glands (Nemeroff, 1996). In the past several 
years, many studies of the HPA axis in depressed 
patients have been published. A new perspective for 
these old findings of hypercortisolemia appears to 
have been generated. Hypercortisolemia is apparently 
linked to some specific cases of depression, depending 
on the type and severity of the illness, genotype, history 
of stress during childhood, and possibly resilience, 
leading us to hypothesize that an endophenotype 
may exist that is prone to depression (Mello et al., 
2007). Previous studies have described impaired HPA 
negative feedback, leading to hypercortisolemia, 
such as in melancholic depression (Nemeroff, 1996; 
Gold, Goodwin, & Chrousos, 1988). In addition to 
melancholic depression, a spectrum of other conditions 
may be associated with increased and prolonged 
activation of the HPA axis, including anorexia nervosa 
with and without malnutrition, obsessive-compulsive 
disorder, panic disorder, anxiety, chronic active 
alcoholism, alcohol and narcotic withdrawal, poorly 
controlled diabetes mellitus, and hyperthyroidism 
(Tsigos & Chrousos, 2002). Another group of states is 
characterized by hypoactivation of the stress system, 
rather than sustained activation, in which chronically 
reduced secretion of CRF may result in pathological 
hypoarousal and enhanced HPA negative feedback. 
Patients with PTSD, atypical depression, seasonal 
depression, and chronic fatigue syndrome fall into 
this category (Kellner & Yehuda, 1999; Juruena et al., 
2004; Juruena & Cleare, 2007; Table 1).
Figure 2. Micro and macro stress in individuals with 
genetic vulnerability and its relationship to neuropsychiatric 
symptoms. Adapted from Juruena et al., 2003.
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One of the mechanisms thought to be involved in 
HPA axis hyperactivity in depression is impaired feedback 
inhibition of the HPA axis by circulating glucocorticoids 
(Pariante & Miller 2001). This impaired feedback inhibition 
has been demonstrated in depressed patients in various 
studies, many conducted in the 1970s and 1980s (Juruena 
et al., 2009; Juruena, Pariante, Papadopoulos, & Cleare, 
2010; Ribeiro, Tandon, Grunhaus, & Greden, 1993). These 
abnormalities appear to be related to changes in the ability 
of circulating glucocorticoids to exert negative feedback on 
the secretion of HPA hormones through binding to MRs and 
GRs in HPA tissue (de Kloet, Vreugdenhil, Oitzl, & Joels, 
1998; Gold et al., 1988; Juruena et al., 2003; Nemeroff, 
1996; Figure 3). The first study of hypercortisolemia in 
depressed patients was published in the 1970s and found 
that severely depressed patients exhibited non-suppression 
in the dexamethasone suppression test (DST). In the DST, a 
high proportion of patients with various affective disorders 
had elevated cortisol levels, thus negating the suppressive 
effect of dexamethasone. Unfortunately, dexamethasone 
has pharmacodynamic and pharmacokinetic features that 
are very distinct from those of the human endogenous 
glucocorticoid cortisol. These features, together with 
the low sensitivity of the DST in detecting patients with 
major depression, have significantly limited the use of this 
test in routine clinical and research practice. Recently, a 
suppressive test that uses another synthetic glucocorticoid, 
prednisolone, was developed by Pariante et al. (2002). This 
test has a higher affinity for MRs and, therefore, should 
probe both receptors (Juruena et al., 2006; Juruena et al., 
2009, 2010; Pariante et al., 2002).
HPA, hypophysis-pituitary-adrenal. Adapted from Juruena et al., 2004.
Table 1 - States associated with hyperactivation or hypoactivation of the HPA axis
	   Figure 3. Schematic diagram of the hypothalamic-pituitary-
adrenal (HPA) axis that describes the regulation and negative 
feedback (-) of cortisol via glucocorticoid receptors (GRs) 
and mineralocorticoid receptors (MRs). Adapted from 
Juruena et al., 2004.
Increased HPA axis activity Decreased HPA axis activity Disrupted HPA axis activity
Severe chronic disease Atypical depression Cushing syndrome
Melancholic depression Seasonal depression Glucocorticoid deficiency
Anorexia nervosa Chronic fatigue syndrome Glucocorticoid resistance
Obsessive-compulsive disorder Fibromyalgia
Panic disorder Hypothyroidism
Chronic excessive exercise Adrenal suppression
Malnutrition Post glucocorticoid therapy
Diabetes mellitus Posttraumatic stress disorder
Hyperthyroidism Nicotine withdrawal
Central obesity Postpartum
Childhood maltreatment Menopause
Pregnancy Rheumatoid arthritis  
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Prediction of response
Generally, HPA axis changes appear in chronic 
depressive and more severe episodes. Moreover, HPA 
axis changes appear to be state-dependent, tending to 
improve upon resolution of the depressive syndrome 
(Holsboer, 2000). Interestingly, persistent HPA 
hyperactivity has been associated with higher rates 
of relapse (Juruena et al., 2009; Ribeiro et al., 1993; 
Zobel, Yassouridis, Frieboes, & Holsboer, 1999). 
Studies conducted in patients who received a range 
of antidepressants have shown that those who fail to 
show a normalization of post-dexamethasone cortisol 
levels tend to have a worse outcome with regard to 
re-hospitalization, suicide, and the recurrence of 
depression (Ribeiro et al., 1993). Recent reports have 
described a prospective study of the relationship 
between the results of the dexamethasone/CRF test 
and clinical outcome. Specifically, Zobel et al. (1999; 
Zobel et al., 2001) described a cohort of patients who 
were subjected to the dexamethasone/CRF test on two 
separate occasions: within 1 week after admission (or 
after the start of the first antidepressant treatment) and 
a few days before discharge. The patients were then 
followed up for 6 months after discharge. The study 
found that the patients who exhibited increased cortisol 
levels after the dexamethasone/CRF test between 
admission and discharge tended to relapse during 
the follow-up period, whereas those who showed a 
decrease in post-dexamethasone/CRF cortisol levels 
tended to remain clinically stable during the follow-
up period (Zobel et al., 1999, 2001). Therefore, these 
studies suggest that the evaluation of the HPA axis 
during antidepressant treatment may help identify 
patients who have a higher risk of relapse (Juruena et 
al., 2009; Zobel et al., 1999).
Synthesis
Studies of the association between early life 
stress and psychiatric disorders should be evaluated 
carefully. No consensus has been reached in the 
literature regarding the concept of early life stress, and 
the respondents in these studies likely underestimated 
or overestimated the frequency/intensity of events. 
Much descriptive work has been published on the 
relationship between adult psychopathology and 
early adversities such as parental loss in childhood, 
inadequate parental care, divorce, “affectionless” or 
dysfunctional parenting, childhood physical and sexual 
abuse, and other childhood traumas. Importantly, 
mood disorders such as depression are most associated 
with the occurrence of early life stress subtypes. The 
results of existing studies suggest the importance 
of preventing early life stress and its consequences 
in both the short and long terms. Intervention at an 
early stage can reduce the likelihood of developing 
health problems in the long term and re-victimization 
in adulthood. Furthermore, early interventions may 
reduce the burden of public spending on healthcare 
for abused individuals.
The more recent studies reviewed in the present 
paper suggest that early life stressors are associated with 
an increased risk for mood disorders in adulthood. This 
review examined the emerging literature concerning 
the relationship between stress, HPA axis function, 
and depression and early life stress as an important 
risk factor for HPA axis dysregulation. The most 
consistent findings in the literature show increased 
activity of the HPA axis in depression associated with 
hypercortisolemia and reduced inhibitory feedback. 
These findings suggest that this dysregulation of the 
HPA axis is partially attributable to an imbalance 
between GRs and MRs. Evidence has consistently 
demonstrated that GR function is impaired in major 
depression, resulting in reduced GR-mediated negative 
feedback on the HPA axis, but few studies have assessed 
the activity of MRs in depression. Thus, although a 
few studies suggested that MR activity remains intact 
or is possibly oversensitive to compensate for reduced 
GR function in depressed patients, more studies are 
needed to elucidate this issue (Young, Lopez, Murphy-
Weinberg, Watson, & Akil, 2003; Juruena et al., 2009, 
2010; Pariante et al., 2001; Pariante, 2006).
Conclusion
Social and physical environments have an 
enormous impact on our physiology and behavior, and 
they influence the process of adaptation or allostasis. 
At the same time that our experiences change our brain 
and thoughts (i.e., changing our mind), we change our 
neurobiology. Although disturbances in the HPA axis 
are an important factor in the etiology of depression 
and severe treatment resistance, very little is known 
about the neurobiology of these disorders. Therefore, 
psychometric assessment that quantifies the level 
of early life stress, recent stress, the evolution of 
affective symptoms and diagnosis, and neuroendocrine 
activity is essential. Childhood stressful events and 
HPA axis overactivity in adulthood are not specific 
to depressive states, but several studies have linked 
these conditions. As demonstrated in this review, early 
life stress leads to permanent changes in the HPA 
axis and may lead to the development of depression 
in adulthood. Considering the importance of early 
detection of violence in childhood and adolescence, 
to prevent the development of severe and disabling 
psychiatric disorders in adulthood, further research is 
needed to elucidate the mechanisms involved in the 
association between early stress and the development 
of psychopathology in adulthood.
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